The Pharma Data
JUNE 14, 2023
Scientists discover small RNA that regulates bacterial infection People with weakened immune systems are at constant risk of infection. Their research findings, published in Nature, can inform the development of future treatments for life-threatening acute infections. Now, we know that oxygen levels are regulating this transition.”
pharmaphorum
DECEMBER 4, 2020
Subject to approval from regulators the vaccine specialist said it plans the trial known as VLA15-221 as a randomised, observer-blind phase 2 study including around 600 healthy people aged 5-65 years of age. OspA is one of the most dominant surface proteins expressed by the bacteria when present in the ticks that spread the disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
SEPTEMBER 22, 2020
The strip did indeed work, showing a positive for the bacterium in about 16 hours and indicating spoilage a few hours after that. To test out this microneedle strip, the researchers injected a piece of raw fish with E. coli , salmonella and a non-contaminated control fluid. They also waited for it to, essentially, rot.
Pharmaceutical Technology
SEPTEMBER 1, 2022
In the pursuit of improving patient care, the continued development of POC testing can help support future demand for rapid diagnosis and treatment, with opportunities to implement successful POC facilities expanding over the years as the technology has improved. To compose one full molecular device, there are many, many components.”.
pharmaphorum
SEPTEMBER 8, 2022
The data from the ongoing study hasn’t yet been made public, but an interim analysis was enough to convince the US regulator that Pfizer’s GBS6 (PF-06760805) should be granted the designation, which could accelerate its passage through regulatory review. It has previously also been given fast-track status.
pharmaphorum
MARCH 2, 2022
The company came out with the usual mantra of evaluating the data and conferring with regulators before deciding on the future of the programme, and said it would present the data in full at an future medical congress. diff vaccine candidate in clinical development is GlaxoSmithKline, whose GSK2904545A is in phase 1.
The Pharma Data
JULY 11, 2021
It is believed to be involved in the development of chronic inflammatory intestinal diseases, to trigger diabetes, to be responsible for obesity, even neurological diseases such as multiple sclerosis and Parkinson’s could have their causes here – not to mention depressions and autistic disorders.
Expert insights. Personalized for you.
40 
Let's personalize your content